10 results
424B3
CMMB
Chemomab Therapeutics Ltd
12 Feb 21
Prospectus supplement
12:05pm
, confidentiality, data security or similar obligations to third parties, or any data security incidents or other security breaches that result … by third parties asserting that we have breached our privacy, confidentiality, data security, or similar obligations, any of which could have
S-4/A
CMMB
Chemomab Therapeutics Ltd
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
failure by us or any third-party collaborators, service providers, contractors or consultants to comply with our privacy, confidentiality, data security … or similar obligations to third parties, or any data security incidents or other security breaches that result in the unauthorized access, release
S-4
EX-2.1
CMMB
Chemomab Therapeutics Ltd
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
and data security of any personally identifiable information and sensitive business information (collectively, “Sensitive Data”) except to the extent … ’ business are in substantial compliance with all Laws pertaining to data privacy and data security of Sensitive Data, except to the extent
S-4
EX-10.7
xhowhpi n3
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
w1z45b365xd8 tozho
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
o18o0d04
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
efpeq14wvyz2e9ckf
15 Dec 20
Additional proxy soliciting materials
3:32pm
10-K
rul hj2r13
17 Mar 20
Annual report
5:27pm
- Prev
- 1
- Next